Add to ORKGDISCLOSURES: Funding for this summary was contributed by Arnold Ventures, California Health Care Foundation, Harvard Pilgrim Health Care, and Kaiser Foundation Health Plan to the Institute for Clinical and Economic Review (ICER), an independent organization that evaluates the evidence on the value of health care interventions. ICERs annual policy summit is supported by dues from Aetna, Americas Health Insurance Plans, Anthem, Allergan, Alnylam, AstraZeneca, Biogen, Blue Shield of CA, Boehringer-Ingelheim, Cambia Health Services, CVS, Editas, Express Scripts, Genentech/Roche, GlaxoSmithKline, Harvard Pilgrim, Health Care Service Corporation, HealthFirst, Health Partners, Johnson & Johnson (Janssen), Kaiser Permanente, LEO Pharma, Mallinc...
Background: cystic fibrosis (CF) is a life-threatening genetic disease, affecting around 10 500 peop...
This is a protocol to describe the methodology for a systematic review of clinical trials registries...
Copyright © 2014 Pritish Mondal et al.This is an open access article distributed under the Creative ...
Introduction: Cystic fibrosis (CF) is a genetic disease affecting multiple organ systems. Research a...
BACKGROUND: Cystic fibrosis (CF) is a chronic, progressive, genetic disease affecting more than 30,0...
Cystic fibrosis (CF) is a common inherited condition caused by mutations in the gene encoding the CF...
Cystic fibrosis is a life-threatening genetic disease that causes severe damage to the lungs. Ivacaf...
BACKGROUND: The ability to restore cystic fibrosis transmembrane regulator (CFTR) function with effe...
Alexandria M Arends,1 Rebecca S Pettit2 1Department of Pharmacy, Indiana University Health, 2Departm...
Cystic fibrosis (CF) is a life-shortening disease with significant morbidity. Despite overall improv...
The first regulatory approval for a drug developed specifically for cystic fibrosis (CF) occurred in...
Introduction: Cystic fibrosis (CF) is a lung disease that involves more than 80,000 people globally....
Cystic fibrosis (CF) is a common inherited condition caused by mutations in the gene encoding the CF...
International audienceBackground: Phase 3 trials have demonstrated the safety and efficacy of lumaca...
Objectives: Cystic fibrosis (CF) is an inherited disease that requires more intensive treatments as ...
Background: cystic fibrosis (CF) is a life-threatening genetic disease, affecting around 10 500 peop...
This is a protocol to describe the methodology for a systematic review of clinical trials registries...
Copyright © 2014 Pritish Mondal et al.This is an open access article distributed under the Creative ...
Introduction: Cystic fibrosis (CF) is a genetic disease affecting multiple organ systems. Research a...
BACKGROUND: Cystic fibrosis (CF) is a chronic, progressive, genetic disease affecting more than 30,0...
Cystic fibrosis (CF) is a common inherited condition caused by mutations in the gene encoding the CF...
Cystic fibrosis is a life-threatening genetic disease that causes severe damage to the lungs. Ivacaf...
BACKGROUND: The ability to restore cystic fibrosis transmembrane regulator (CFTR) function with effe...
Alexandria M Arends,1 Rebecca S Pettit2 1Department of Pharmacy, Indiana University Health, 2Departm...
Cystic fibrosis (CF) is a life-shortening disease with significant morbidity. Despite overall improv...
The first regulatory approval for a drug developed specifically for cystic fibrosis (CF) occurred in...
Introduction: Cystic fibrosis (CF) is a lung disease that involves more than 80,000 people globally....
Cystic fibrosis (CF) is a common inherited condition caused by mutations in the gene encoding the CF...
International audienceBackground: Phase 3 trials have demonstrated the safety and efficacy of lumaca...
Objectives: Cystic fibrosis (CF) is an inherited disease that requires more intensive treatments as ...
Background: cystic fibrosis (CF) is a life-threatening genetic disease, affecting around 10 500 peop...
This is a protocol to describe the methodology for a systematic review of clinical trials registries...
Copyright © 2014 Pritish Mondal et al.This is an open access article distributed under the Creative ...